2m 2m 2m 2m 2m 2m 2m
Genmab (GNMSF)
OTC
$285.85+$10.06 (+3.65%)
Price as of Jul 13, 2026- N/AMarket Cap
- 32.98%1-Year Change
- BiotechnologyIndustry
Genmab (GNMSF)
$285.85+$10.06 (+3.65%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$285.85
$291.86
$285.85
1-Year Range
$208.80
$352.00
$285.85
Latest Close$285.85
Change
+$10.06 (+3.52%)
Volume244
Information as of 07/13/2026
Company Profile
GENMAB A/S DKK
N/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Biotechnology
GENMAB A/S DKK
Key Executives
- Jan van de Winkel
- Rayne Waller
- Gregory David Emil Mueller
- Tahamtan Ahmadi
- Judith V. Klimovsky
Current Ownership Distribution
- Other55.6M (90.57%)
- Mutual Funds5.8M (9.39%)
- Institutions22,840 (0.04%)
- Insiders0 (0.00%)